螺内酯联合贝那普利治疗慢性充血性心力衰竭47例疗效观察

目的探讨螺内酯联合贝那普利治疗慢性充血性心力衰竭的疗效。方法将我院收治的94例慢性充血性心力衰竭患者随机分为螺内酯联合贝那普利治疗组（观察组）和贝那普利治疗组（对照组），每组各47例，比较两组患者的，隘床疗效。结果观察组患者治疗总有效率为91．5％，显著高于对照组患者的74．5％，组间差异有统计学意义（P〈0．05）。两组患者治疗期间均未出现明显不良反应。结论螺内酯联合贝那普利治疗慢性充血性心力衰竭临床疗效确切，值得临床进一步推广使用。

Clinical Effect Observation of Spironolactone Combined with Benazepri in Treatment of 47 Cases with Chronic Congestive Heart Failure

Objective To explore the clinical effect of spironolactone combined with＇benazepri in treatment of chronic congestive heart failure. Methods 94 patients with chronic congestive heart failure in our hospital were randomly divided into spironolactone combined with benazepri treatment group （observation group） and benazepri treatment group （control group）, 47 cases in each group, compared the clinical effect of patients in two groups. Results The total effective rate of patients in observation group was 91.5%, significantly higher than that in control group （74.5%）, there was significant difference between two groups （P〈0.05）. There were no obvious adverse reactions during treatment. Conclusion Taking spironolactone combined with benazepri in the treatment of chronic congestive heart failure has effective clinical effect, worthy of further clinical application.